Kung Winston
- SEC CIK
- 0001666963
In the past year, 1 open-market sale filing worth $16.0K and no purchases.
Current role at each company
- JANX Janux Therapeutics, Inc.Directoras of Jun 12, 2026
- CRBP Corbus Pharmaceuticals Holdings, Inc.Directoras of Jun 11, 2026
- AVBP ArriVent BioPharma, Inc.Chief Financial Officeras of Feb 4, 2026
- PMVP PMV Pharmaceuticals, Inc.COO, CFOas of May 15, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $16.0K
- 1 filing
- Net
- −$16.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kung Winston as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRBP Corbus Pharmaceuticals Holdings, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 (view filing) | Jun 10 | 1 day | Kung WinstonDirector | SSaleCommon Stock, par value $0.0001 per share | −2.03K | $7.91 | −$16.0K | −14.3%12.1K after | 10b5-1 |
PMVP PMV Pharmaceuticals, Inc.
COO, CFO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2021 (view filing) | Jul 8 | Same day | Kung WinstonCOO, CFO | SSale | −4.50K | $33.75 | −$151.9K | −73.8%1.60K after | |
| Aug 4, 2021 (view filing) | Aug 3 | 1 day | Kung WinstonCOO, CFO | SSale | −4.50K | $33.82 | −$152.2K | −73.8%1.60K after |